Corporate ActionAug 6, 2026, 05:15 PM
Latigo Biotherapeutics Increases Share Offering by 3.68M
AI Summary
Latigo Biotherapeutics, Inc. filed an S-1MEF registration statement to increase the number of common shares offered and registered in its public offering. The company is registering an additional 3,680,000 shares, which includes 480,000 shares subject to the underwriters' option to purchase additional stock. This filing is made pursuant to Rule 462(b) and incorporates the earlier S-1 registration statement (File No. 333-297518), which became effective on August 6, 2026.
Key Highlights
- Latigo Biotherapeutics filed an S-1MEF to increase shares offered in its public registration.
- An additional 3,680,000 shares of common stock are being registered.
- This includes 480,000 shares subject to the underwriters' option to purchase additional stock.
- The filing is made pursuant to Rule 462(b) of the Securities Act of 1933.
- It incorporates by reference the earlier S-1 registration statement (File No. 333-297518).
- The earlier S-1 registration statement was declared effective on August 6, 2026.
Price Impact
More from LTGO